Update on epidemiology of hepatitis B and C in China
Authors:
Open Access
- 15 July 2013
- journal article
- review article
- Published by Wiley in Journal of Gastroenterology and Hepatology
- Vol. 28 (S1) , 7-10
Abstract
Graphic A high rate of chronic hepatitis B virus (HBV) infection in China is mainly caused by perinatal or early childhood transmission. Administration of universal HBV vaccination in infants has led to a dramatic decrease in HBV epidemiology, with hepatitis B surface antigen (HBsAg) prevalence declining from 9.75% in 1992 to 7.18% in 2006. The major HBV genotypes are B and C, with B being more prevalent in the southern part and C more prevalent in the northern part of China. A national survey carried out in 1992 showed that the hepatitis C virus (HCV) infection rate was 3.20% in general population in China. After implementation of mandatory HCV screening for blood transfusion and other precautions to prevent blood‐borne disease since 1993, the new cases of HCV infection associated with blood or blood product has become very rare. Although the anti‐HCV prevalence would be much higher in high‐risk groups, a survey carried in 2006 showed that the anti‐HCV prevalence rate was only 0.43% in general population. This sharp decline in HCV infection rate was mainly due to stringent administration and monitoring of blood donors and blood products, but may also be related to the remarkably improved specificity of anti‐HCV test. The predominant HCV genotype in China is genotype 1b (60–70%), and the host interleukin‐28b rs12979860 CC genotype is very frequent in Chinese population (over 80%).Keywords
Funding Information
- Beijing Municipal Science & Technology Commission (D121100003912003)
- Major State Basic Research Development Program (2013ZX10002004-001-001, 2013ZX10002004-002-002)
This publication has 31 references indexed in Scilit:
- Efficacy of yeast-derived recombinant hepatitis B vaccine after being used for 12 years in highly endemic areas in ChinaVaccine, 2012
- Long-term efficacy of 10–12 years after being immunized with Chinese hamster ovary cell derived hepatitis B vaccine in Chinese Rural CommunitiesVaccine, 2012
- Control of hepatitis B in China: prevention and treatmentExpert Review of Anti-infective Therapy, 2011
- Hepatitis B virus infection and related factors in hemodialysis patients in China – systematic review and meta-analysisRenal Failure, 2010
- Factors associated with effectiveness of the first dose of hepatitis B vaccine in China: 1992–2005Vaccine, 2010
- Prevalence of hepatitis C virus and hepatitis B virus infections in HIV-positive Chinese patientsEpidemiology and Infection, 2010
- A significant reduction in hepatitis B virus infection among the children of Shandong Province, China: the effect of 15 years of universal infant hepatitis B vaccinationInternational Journal of Infectious Diseases, 2010
- Epidemiological serosurvey of Hepatitis B in China—Declining HBV prevalence due to Hepatitis B vaccinationVaccine, 2009
- Evaluation of the Impact of Hepatitis B Vaccination among Children Born during 1992–2005 in ChinaThe Journal of Infectious Diseases, 2009
- Prevalence of hepatitis B and C virus infections in the general Chinese population. Results from a nationwide cross-sectional seroepidemiologic study of hepatitis A, B, C, D, and E virus infections in China, 1992International Hepatology Communications, 1996